acetosulfam (CID 11074431) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(4)
 
 
Inactive(267)
 
 
Inconclusive(12)
 
 
Unspecified(4)
 
 
Top Targets:
NR LBD PPAR(10)
 
 
 
NR LBD TR(8)
 
 
 
NR LBD VDR(5)
 
 
 
NR LBD Fxr(4)
 
 
NR LBD ER(4)
 
 
 
BioAssay Types:
Confirmatory(193)
 
 
 
Literature(70)
 
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(157)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 183    Data Row: 287   Total Pages: 6   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID160687838]
 Anticonvulsant activity against maximal electroshock-induced seizures in Swiss mouse at 300 mg/kg, ip after 0.5 hrs [AID665433, Type: Literature]
View
2
[SID160687838]
 Anticonvulsant activity against maximal electroshock-induced seizures in Swiss mouse at 30 mg/kg, ip after 4 hrs [AID665434, Type: Literature]
View
3
[SID160687838]
 Anticonvulsant activity against maximal electroshock-induced seizures in Swiss mouse at 100 mg/kg, ip after 4 hrs [AID665435, Type: Literature]
View
4
[SID160687838]
 Anticonvulsant activity against maximal electroshock-induced seizures in Swiss mouse at 300 mg/kg, ip after 4 hrs [AID665436, Type: Literature]
View
5
[SID160687838]
 Neurotoxicity against Swiss mouse at 30 to 300 mg/kg, ip after 4 hrs by rotarod ataxia test [AID665437, Type: Literature]
View
6
[SID17389209]
 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
7
[SID26752766]
 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
8
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View
9
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_1, Type: Literature]
View
10
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_2, Type: Literature]
View
11
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature]
View
12
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_4, Type: Literature]
View
13
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_5, Type: Literature]
View
14
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_6, Type: Literature]
View
15
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_7, Type: Literature]
View
16
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_8, Type: Literature]
View
17
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_9, Type: Literature]
View
18
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_10, Type: Literature]
View
19
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_11, Type: Literature]
View
20
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_12, Type: Literature]
View
21
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_13, Type: Literature]
View
22
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_14, Type: Literature]
View
23
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_15, Type: Literature]
View
24
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_16, Type: Literature]
View
25
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_17, Type: Literature]
View
26
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_18, Type: Literature]
View
27
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_19, Type: Literature]
View
28
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_20, Type: Literature]
View
29
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_21, Type: Literature]
View
30
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_22, Type: Literature]
View
31
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_23, Type: Literature]
View
32
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_24, Type: Literature]
View
33
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_25, Type: Literature]
View
34
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_26, Type: Literature]
View
35
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_27, Type: Literature]
View
36
[SID17389209]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_28, Type: Literature]
View
37
[SID17389209]
Potency qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia [AID1477, Type: confirmatory]
View
38
[SID17389209]
Potency S16 Schwann cell viability assay (CellTiter-Glo assay) [AID624031, Type: confirmatory]
View
39
[SID17389209]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory]
View
40
[SID17389209]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory]
View
41
[SID17389209]
 Cell Viability - N2a [AID540, Type: confirmatory]
View
42
[SID17389209]
 Cell Viability - NIH 3T3 [AID541, Type: confirmatory]
View
43
[SID17389209]
 Cell Viability - HUV-EC-C [AID542, Type: confirmatory]
View
44
[SID17389209]
 Cell Viability - H-4-II-E [AID543, Type: confirmatory]
View
45
[SID17389209]
 Cell Viability - SH-SY5Y [AID544, Type: confirmatory]
View
46
[SID17389209]
 Cell Viability - Renal Proximal Tubule [AID545, Type: confirmatory]
View
47
[SID17389209]
 Cell Viability - Mesenchymal [AID546, Type: confirmatory]
View
48
[SID17389209]
 Cell Viability - HepG2 [AID433, Type: confirmatory]
View
49
[SID17389209]
 Cell Viability - MRC5 [AID434, Type: confirmatory]
View
50
[SID17389209]
 Cell Viability - SK-N-SH [AID435, Type: confirmatory]
View